TTM
−$1.37B
YoY change
+88.5%
5Y CAGR
—
Peak year (2017)
−$31.13M
Cumulative net income
−$3.29B
Net Income history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: −$1.13B
Net Income growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: +88.5%
Net Income history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | −$1.13B | +88.5% | −$531.21M | ||
| 2024 | −$600.09M | +37.5% | −$163.73M | ||
| 2023 | −$436.37M | +75.5% | −$187.66M | ||
| 2022 | −$248.71M | +32.9% | −$61.61M | ||
| 2021 | −$187.09M | +73.0% | −$78.93M | ||
| 2020 | −$108.16M | +126.9% | −$60.49M | ||
| 2019 | −$47.66M | +14.1% | −$5.88M | ||
| 2018 | −$41.79M | +34.3% | −$10.66M | ||
| 2017 | −$31.13M | — | — |
- 2025−$1.13B+88.5%
- 2024−$600.09M+37.5%
- 2023−$436.37M+75.5%
- 2022−$248.71M+32.9%
- 2021−$187.09M+73.0%
- 2020−$108.16M+126.9%
- 2019−$47.66M+14.1%
- 2018−$41.79M+34.3%
- 2017−$31.13M—
Net Income values are taken from Revolution Medicines's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current net income (TTM) is −$1.37B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Revolution Medicines (RVMD) net income is −$1.13B – surged 88.5% year-over-year.
−$31.13M stands as the all-time-high annual net income, posted in 2017, against a low of −$1.13B during 2025.
Revolution Medicines Net Income by Year
Revolution Medicines Net Income 2025: −$1.13B
Revolution Medicines net income in 2025 was −$1.13B, surged 88.5% from 2024. This figure represents the lowest annual value in the available history.
Revolution Medicines Net Income 2024: −$600.09M
2024's net income for Revolution Medicines came in at −$600.09M, surged 37.5% from 2023.
Revolution Medicines Net Income 2023: −$436.37M
Revolution Medicines posted net income of −$436.37M in 2023, surged 75.5% from 2022.
Revolution Medicines Net Income 2022: −$248.71M
In 2022, Revolution Medicines reported net income of −$248.71M, surged 32.9% from 2021.
Revolution Medicines Net Income 2021: −$187.09M
Revolution Medicines net income in 2021 was −$187.09M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Net Income
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation